Recently, a key opinion leader in psychiatry, offered this clarification on social media:
“I do not receive funding from pharmaceutical companies. I have contributed as a speaker or discussant to scientific meetings within professional organisations that receive sponsorship but I can’t think of anything else in past 10 years.”
This ‘clarification’ would not have been necessary if the UK had introduced Sunshine legislation. This ‘clarification’ has also missed the opportunity to acknowledge the past contribution of partnership with industry which can be a key part in the career progression of academics and clinicians who have become today’s key opinion leaders. These influential professionals are in the privileged position of being able to influence the current narrative, including selecting which details of their own relationships with industry [both past and present] may need ‘clarification’.